Literature DB >> 18384750

Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-beta signaling.

Seiyu Imoto1, Norihiko Ohbayashi, Osamu Ikeda, Shinya Kamitani, Ryuta Muromoto, Yuichi Sekine, Tadashi Matsuda.   

Abstract

Sma- and MAD-related protein 3 (Smad3) plays crucial roles in the transforming growth factor-beta (TGF-beta)-mediated signaling pathway, which produce a variety of cellular responses, including cell proliferation and differentiation. In our previous study, we demonstrated that protein inhibitor of activated STATy (PIASy) suppresses TGF-beta signaling by interacting with and sumoylating Smad3. In the present study, we examined the molecular mechanisms of Smad3 sumoylation during PIASy-mediated suppression of TGF-beta signaling. We found that small-interfering RNA-mediated reduction of endogenous PIASy expression enhanced TGF-beta-induced gene expression. Importantly, coexpression of Smad3 with PIASy and SUMO1 affected the DNA-binding activity of Smad3. Furthermore, coexpression of Smad3 with PIASy and SUMO1 stimulated the nuclear export of Smad3. Finally, fluorescence resonance energy transfer analyses revealed that Smad3 interacted with SUMO1 in the cytoplasm. These results suggest that PIASy regulates TGF-beta/Smad3-mediated signaling by stimulating sumoylation and nuclear export of Smad3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18384750     DOI: 10.1016/j.bbrc.2008.03.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

Review 1.  Emerging roles of SUMO modification in arthritis.

Authors:  Dongyao Yan; Francesca J Davis; Andrew D Sharrocks; Hee-Jeong Im
Journal:  Gene       Date:  2010-07-11       Impact factor: 3.688

Review 2.  Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.

Authors:  Dimphna H Meijer; Michael F Kane; Shwetal Mehta; Hongye Liu; Emily Harrington; Christopher M Taylor; Charles D Stiles; David H Rowitch
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

3.  Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization.

Authors:  Stephen R Fuhs; Paul A Insel
Journal:  J Biol Chem       Date:  2011-03-01       Impact factor: 5.157

4.  ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor β Signaling through a Direct Interaction with Smad3.

Authors:  Xing Liu; Zhu Chen; Gang Ouyang; Tieshan Song; Huageng Liang; Wei Liu; Wuhan Xiao
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

Review 5.  Biologic Therapy in Chronic Pain Management: a Review of the Clinical Data and Future Investigations.

Authors:  Mark Whitney Motejunas; Lauren Bonneval; Cleo Carter; Devin Reed; Ken Ehrhardt
Journal:  Curr Pain Headache Rep       Date:  2021-03-24

6.  Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation.

Authors:  Guang Gao; Jerry Wong; Jingchun Zhang; Ivy Mao; Jayant Shravah; Yan Wu; Allen Xiao; Xiaotao Li; Honglin Luo
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

7.  Therapeutic targets in fibrotic pathways.

Authors:  Travis Lear; Bill B Chen
Journal:  Cytokine       Date:  2016-09-19       Impact factor: 3.861

Review 8.  Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.

Authors:  Shuang Li; Jing Zhao; Dong Shang; Daniel J Kass; Yutong Zhao
Journal:  JCI Insight       Date:  2018-05-17

9.  SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4.

Authors:  Jianmei W Leavenworth; Xiaojing Ma; Yin-yuan Mo; Mary E Pauza
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

Review 10.  A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Authors:  Ellen Van Damme; Kris Laukens; Thanh Hai Dang; Xaveer Van Ostade
Journal:  Int J Biol Sci       Date:  2010-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.